{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:10Z","timestamp":1740149830088,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12288-019-01168-9","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T16:03:42Z","timestamp":1565107422000},"page":"78-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-289X","authenticated-orcid":false,"given":"P\u0131nar","family":"C\u00f6mert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkerim","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hacer Berna","family":"Afacan \u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c7i\u011fdem","family":"Pala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"Ayl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"issue":"20","key":"1168_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"key":"1168_CR2","unstructured":"Morin RD, Marra MA, Mungall AJ, Hirst M, Mendez-Lago M, Gascoyne RD et al. (2018) Biomarkers for non-hodgkin lymphomas and uses thereof. Google Patents"},{"key":"1168_CR3","first-page":"168","volume":"2","author":"S Rosenberg","year":"1975","unstructured":"Rosenberg S, Dorfman R, Kaplan H (1975) A summary of the results of a review of 405 patients with non-Hodgkin's lymphoma at Stanford University. Br J Cancer Suppl 2:168","journal-title":"Br J Cancer Suppl"},{"issue":"10","key":"1168_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.clml.2016.08.011","volume":"16","author":"F Cabanillas","year":"2016","unstructured":"Cabanillas F, Rivera N, Pardo WI (2016) Indolent Lymphomas that present with clinically aggressive features: a subset of low-grade lymphomas with a behavior inconsistent with the histologic diagnosis. Clin Lymphoma Myeloma Leukemia. 16(10):550\u2013557","journal-title":"Clin Lymphoma Myeloma Leukemia."},{"key":"1168_CR5","doi-asserted-by":"crossref","unstructured":"Arcaini L, Rattotti S, Gotti M, Luminari S (2012) Prognostic assessment in patients with indolent B-cell lymphomas. Sci World J 2012: 107892","DOI":"10.1100\/2012\/107892"},{"issue":"27","key":"1168_CR6","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U et al (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27(27):4555\u20134562","journal-title":"J Clin Oncol"},{"issue":"20","key":"1168_CR7","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1182\/blood-2012-09-452805","volume":"120","author":"CJ Wu","year":"2012","unstructured":"Wu CJ (2012) CLL clonal heterogeneity: an ecology of competing subpopulations. Blood 120(20):4117\u20134118","journal-title":"Blood"},{"issue":"4","key":"1168_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s11899-009-0027-0","volume":"4","author":"M Federico","year":"2009","unstructured":"Federico M, Molica S, Bellei M, Luminari S (2009) Prognostic factors in low-grade non-Hodgkin lymphomas. Curr Hematol Malignancy Rep 4(4):202\u2013210","journal-title":"Curr Hematol Malignancy Rep"},{"issue":"1","key":"1168_CR9","first-page":"295","volume":"2006","author":"LH Sehn","year":"2006","unstructured":"Sehn LH (2006) Optimal use of prognostic factors in non-Hodgkin lymphoma. ASH Educ Program Book 2006(1):295\u2013302","journal-title":"ASH Education Program Book."},{"issue":"6","key":"1168_CR10","first-page":"297","volume":"86","author":"E Aulbert","year":"1991","unstructured":"Aulbert E, Fromm H, Hornemann H (1991) Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia. Medizinische Klinik (Munich, Germany: 1983) 86(6):297\u2013304","journal-title":"Medizinische Klinik (Munich, Germany: 1983)"},{"issue":"1","key":"1168_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ajh.2830090103","volume":"9","author":"Y Matzner","year":"1980","unstructured":"Matzner Y, Konijn A, Hershko C (1980) Serum ferritin in hematologic malignancies. Am J Hematol 9(1):13\u201322","journal-title":"Am J Hematol"},{"issue":"3","key":"1168_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000206306","volume":"73","author":"K Ohnishi","year":"1985","unstructured":"Ohnishi K, Shimizu K, Yamada H, Kunii A (1985) Quantification of ferritin-secreting cells in patients with non-Hodgkin\u2019s lymphoma. Acta Haematol 73(3):145\u2013149","journal-title":"Acta Haematol"},{"issue":"5","key":"1168_CR13","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s13277-012-0426-z","volume":"33","author":"M Kalousov\u00e1","year":"2012","unstructured":"Kalousov\u00e1 M, Krechler T, J\u00e1chymov\u00e1 M, Kub\u011bna AA, \u017d\u00e1k A, Zima T (2012) Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study. Tumor Biol 33(5):1695\u20131700","journal-title":"Tumor Biol"},{"key":"1168_CR14","unstructured":"Alkhateeb AA, Connor JR (2013) The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. Biochim Biophys Acta (BBA)-Rev Cancer. 1836(2):245\u201354"},{"issue":"8","key":"1168_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbagen.2010.03.017","volume":"1800","author":"Ahmed A. Alkhateeb","year":"2010","unstructured":"Alkhateeb AA, Connor JR (2010) Nuclear ferritin: a new role for ferritin in cell biology. Biochim Biophys Acta (BBA)-Gen Sub 1800(8):793\u20137","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"issue":"1\u20132","key":"1168_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaut.2007.11.003","volume":"30","author":"S Recalcati","year":"2008","unstructured":"Recalcati S, Invernizzi P, Arosio P, Cairo G (2008) New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30(1\u20132):84\u201389","journal-title":"J Autoimmun"},{"issue":"1","key":"1168_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clml.2013.09.008","volume":"14","author":"KA Yoh","year":"2014","unstructured":"Yoh KA, Lee HS, Park LC, Lee EM, Shin SH, Park DJ et al (2014) The prognostic significance of elevated levels of serum ferritin before chemotherapy in patients with non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leukemia 14(1):43\u201349","journal-title":"Clinical Lymphoma Myeloma and Leukemia."},{"issue":"12","key":"1168_CR18","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1002\/1097-0142(19831215)52:12<2308::AID-CNCR2820521225>3.0.CO;2-7","volume":"52","author":"MH D\u00f6rner","year":"1983","unstructured":"D\u00f6rner MH, Abel U, Fritze D, Manke HG, Drings P (1983) Serum ferritin in relation to the course of Hodgkin's disease. Cancer 52(12):2308\u20132312","journal-title":"Cancer"},{"issue":"1","key":"1168_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/ijlh.12592","volume":"39","author":"S Koyama","year":"2017","unstructured":"Koyama S, Fujisawa S, Watanabe R, Itabashi M, Ishibashi D, Ishii Y et al (2017) Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma. Int J Lab Hematol 39(1):112\u2013117","journal-title":"International journal of laboratory hematology."},{"issue":"15","key":"1168_CR20","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.7314\/APJCP.2014.15.15.6099","volume":"15","author":"X-Z Zhang","year":"2014","unstructured":"Zhang X-Z, Su A-L, Hu M-Q, Zhang X-Q, Xu Y-L (2014) Elevated serum ferritin levels in patients with hematologic malignancies. Asian Pac J Cancer Prev. 15(15):6099\u20136101","journal-title":"Asian Pac J Cancer Prev."},{"issue":"2","key":"1168_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000216735","volume":"13","author":"E Aulbert","year":"1990","unstructured":"Aulbert E, Steffens O (1990) Serum ferritin\u2013a tumor marker in malignant lymphomas? Onkologie 13(2):102\u2013108. \nhttps:\/\/doi.org\/10.1159\/000216735","journal-title":"Onkologie."}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-019-01168-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-019-01168-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-019-01168-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T23:28:06Z","timestamp":1596583686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-019-01168-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1168"],"URL":"https:\/\/doi.org\/10.1007\/s12288-019-01168-9","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"type":"print","value":"0971-4502"},{"type":"electronic","value":"0974-0449"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"They authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}